ClearPoint Neuro, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Notes Payable (Details Narrative 1)

Notes Payable (Details Narrative 1)				1 Months Ended		12 Months Ended
Notes Payable (Details Narrative 1)	Sep. 02, 2016 USD ($)	Sep. 02, 2016 shares	Aug. 31, 2016 USD ($) shares	Jun. 30, 2016 USD ($) shares	Nov. 30, 2010 USD ($) Number shares	Dec. 31, 2016 USD ($)	Dec. 31, 2015 USD ($)
Debt Instrument [Line Items]
Common stock fair value					$ 2,775,300
Unamortized discount						$ 2,424,457
Reduction in warrants from debt conversions						(1,207,813)
First Amendments [Member]
Debt Instrument [Line Items]
Fair value				$ 820,000
Second Amendment (2016 PIPE) [Member]
Debt Instrument [Line Items]
Reduction in warrants from debt conversions	$ 1,207,813
Officer [Member]
Debt Instrument [Line Items]
Number of unit issued \| shares					22,068
Number of officers and directors \| Number					4
Value of unit issued \| shares					247,164
Non-Employee Directors [Member]
Debt Instrument [Line Items]
Number of unit issued \| shares					14,180
Number of officers and directors \| Number					3
Value of unit issued \| shares					158,816
2010 Junior Secured Notes Payable [Member]
Debt Instrument [Line Items]
Description of unit					Units consisting of a junior secured note (the “2010 Secured Notes”) and one share of the Company’s common stock.
Number of unit issued \| shares					267,857
Debt face amount					$ 3,000,000
Proceeds from debt issuance					$ 3,000,000
Description of maturity date					Mature in November 2020
Stated interest rate					3.50%
Description of collateral terms					Collateralized by a security interest in the assets of the Company, which security interest is junior and subordinate to the security interests that collateralize the Brainlab Note and the 2014 Secured Notes.
Description of payment terms					Interest on the 2010 Secured Notes will be due and payable in a single payment upon maturity.
Unamortized discount					$ 2,775,300	$ 2,302,472	$ 2,535,230
Interest expense terms					10-year term of the notes using the effective interest method.
New Brainlab Note [Member] \| First Amendments [Member]
Debt Instrument [Line Items]
Debt face amount				$ 500,000
Number of warrants issued \| shares				34,957
New Brainlab Note [Member] \| Non-Employee Directors [Member] \| First Amendments [Member]
Debt Instrument [Line Items]
Debt face amount				$ 3,000,000
Secured Notes 2014 [Member] \| First Amendments [Member]
Debt Instrument [Line Items]
Debt face amount				$ 1,500,000
Number of warrants issued \| shares				11,250
Secured Notes 2014 [Member] \| Second Amendment (2016 PIPE) [Member]
Debt Instrument [Line Items]
Number of unit issued \| shares		350,000
Debt face amount			$ 1,750,000
Fair value			$ 933,000
Number of warrants issued \| shares			13,125